A novel long-term therapy of facial synkinesis with botulinum neurotoxins type a and fillers

Journal of Clinical and Aesthetic Dermatology

Volumn 4, Issue 3, 2011, Pages

  Wiener, Adam ^a   Touloei, Khasha ^b   Glick, Bradley P ^a  

^a Wellington Regional Medical Center   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; VALACICLOVIR;

ADULT; ARTICLE; CASE REPORT; FACE ASYMMETRY; FACIAL SYNKINESIS; FEMALE; HUMAN; MUSCLE RESECTION; MUSCLE SPASM; MYALGIA; NEUROLYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITY OF LIFE; SYNKINESIS; WEIGHT GAIN;

EID: 79953130037     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Beurskens CHG, Oosterhof Jan, Nijhuis-van der Sanden MWG. Frequency and location of synkinesis in patients with peripheral facial nerve paresis. Otol Neurotol. 2010;31(4): 671-675.
2. Moran CJ, Neely JG. Patterns of facial nerve synkinesis. Laryngoscope. 1996;106(12 Pt 1);1491-1496.
3. Chua CAN, Quhill F, Jones E, et al. Treatment of aberrant facial nerve regeneration with botulinum toxin. Orbit. 2004;23:213-218.
4. Adour KK, Byl FM, Hilsinger RL, Kahn ZM, Sheldon MI. The true nature of Bell's palsy: analysis of 1000 consecutive patients. Laryngoscope. 1978;88:787-801.
5. Manikandan N. Effect of facial neuromuscular re-education on facial symmetry in patients with Bell's palsy: a randomized controlled trial. Clin Rehabil. 2007;21(4):338-343.
6. Laskawi R. The use of botulinum toxin in head and face medicine: an interdisciplinary field. Head Face Med. 2008;4:5.
7. Husseman J, Metha RP. Management of synkinesis. Facial Plast Surg. 2008;24:242-249.
8. Guerrissi JO. Selective myectomy for post paretic facial synkinesis. Facial Plast Surg. 1991;87:459-466.
9. Esslen E. Electromyographic findings on two types of misdirection of regenerating axons. EEG Clin Neuro Physiol. 1960;12:738-741.
10. Ide C, Karo S. Peripheral nerve regeneration. Neurosci Res Suppl. 1990;13:157-164.
11. May M. Microanatomy and pathophysiology. In: May M, Schaitkin B, eds. The Facial Nerve. New York: Thieme; 2000:57-65.
12. Yamaoto E, Nishimura H, Hirono Y. Occurrence of sequelae in Bell's palsy. Acta Otolaryngol Suppl. 1988;446:93-96.
13. Celik M, Forta H, Vural C. The development of synkinesis after facial nerve paralysis. Eur Neurol. 2000;43:147-151.
14. Diels JH. New concepts in nonsurgical facial nerve rehabilitation. Adv Otolaryngol Head Neck Surg. 1995;9: 289-315.
15. Segal B, Hunter T, Danys I, Freedman C, Black M. Minimizing synkinesis during rehabilitation of the paralyzed face: preliminary assessment of a new small-movement therapy. J Otolaryngol. 1995;24:149-153.
16. Brach JS, VanSwearingen JM, Lenert J, Johnson PC. Facial neuromuscular retraining for oral synkinesis. Plast Reconstr Surg. 1997;99(7):1922-1931.
17. Beurskens CHG, Devriese PP, van Heiningen I, Oostendorp RAB. The use of mime therapy as a rehabilitation method for patients with facial nerve paresis. Int J Ther Rehab. 2004a;11:206-210.
18. Beurskens CH, Heymans PG. Mime therapy improve facial symmetry in people with long term facial nerve paresis: a randomized controlled trial. Aust J Physiother. 2006;52: 177-183.
19. Yanagihara N, Hato N, Murakami S, Honda N. Transmastoid decompression as a treatment of Bell's palsy. Otolaryngol Head Neck Surg. 2001;124:282-286.
20. Nakamura K, Toda N, Sakamaki K, Kashima K, Takeda N. Biofeedback rehabilitation for prevention of synkinesis after facial palsy. Otolaryngol Head Neck Surg. 2003;128(4): 539-543.
21. Ross B, Nedzelski JM, Mclean JA. Efficacy of feedback training in long-standing facial nerve paresis. Laryngoscope. 1991;101:744-750.
22. Nakamura K, Toda N, Sakamaki K, Kashima K, Takeda N. Biofeedback rehabilitation for prevention of synkinesis after facial palsy. Otolaryngol Head Neck Surg. 2003;128: 539-543.
23. Borodic G, Bartley M, Slattery W, et al. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg. 2005;116:36-43.
24. To EWH, Ahuja AT, Ho WS, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyogrpahic measurement. Br J Plast Surg. 2001;54:197-200.
25. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Opthalmol. 1980;87:1044-1049.
26. Roggenkamper P, Laskawi R, Damenz W, Schroder M, Nussgens Z. Botulinum toxin treatment of synkinesis following facial paralysis. HNO. 1990;38:295-297.
27. Armstrong MW, Mountain RE, Marray JA. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol Allied Sci. 1996;21:15-20.
28. Smet-Dieleman H, Van de Heyning PH, Tassignor MJ. Botulinum A toxin injection in patient with facial nerve palsy. Acta Otorhinolaryngol Belg. 1993;47:359-363.
29. Mountain RE, Murray JA, Quaba A. Management of facial synkinesis with Clostridium botulinum toxic injection. Clin Otolaryngol Allied Sci. 1992;17:223-224.
30. Roggenkamper P, Kaskawi R, Damenz W, Shroder M, Nussgens Z. Involuntary lid closure caused by defective healing of facial paralysis and its treatment with botulinum toxin. Klin Monatsbl Augenheilkd. 1991:268-270.
31. Arikan OK, Tan FU, Kendi T, Koc C. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy. J Otolaryngol. 2006;35:40-43.
32. Roggenkamper P, Laskawi R, Damenz W, Schroder M, Nussgens Z. Orbicular synkinesis after facial nerve paralysis: treatment with botulinum toxin. Doc Opthalmol. 1994;86: 395-402.
33. Ito H, Nakano S, Kusaka H. Low dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation. Acta Neurol Scan. 2007:115:271-274.
34. Borodic G, Bartley M, Slattery W, et al. Botulinum toxin for aberrant facial nerve regeneration: double blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg. 2005;116:36-43.
35. Mancini R, Khadavi NM, Goldberg RA. Nonsurgical management of upper eyelid margin asymmetry using hyaluronic acid gel filler. Ophthal Plast Reconstr Surg. 2011;27(1):1-3.